AARTI PHARMALABS
Back to Balance Sheet
|
AARTI PHARMALABS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹420 Cr | ₹259 Cr | ₹131 Cr | ₹85 Cr | ₹73 Cr |
What is the latest Total Non-Current Liabilities ratio of AARTI PHARMALABS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹420 Cr |
| Mar2025 | ₹259 Cr |
| Mar2024 | ₹131 Cr |
| Mar2023 | ₹85 Cr |
| Mar2022 | ₹73 Cr |
How is Total Non-Current Liabilities of AARTI PHARMALABS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹420 Cr | 61.70 | |
| Mar2025 | ₹259 Cr | 98.54 | |
| Mar2024 | ₹131 Cr | 53.89 | |
| Mar2023 | ₹85 Cr | 16.71 | |
| Mar2022 | ₹73 Cr | - | |
Compare Total Non-Current Liabilities of peers of AARTI PHARMALABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI PHARMALABS | ₹7,870.5 Cr | 6.6% | 26% | 2.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,791.0 Cr | 1.7% | -1.4% | 21.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹245,081.0 Cr | 2% | 10.3% | 49.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,351.0 Cr | -0.4% | -0.5% | 38.6% | Stock Analytics | |
| CIPLA | ₹114,163.0 Cr | -0.5% | -2.5% | -10.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.3 Cr | -1.2% | 0% | -7.1% | Stock Analytics | |
AARTI PHARMALABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI PHARMALABS | 6.6% |
26% |
2.5% |
| SENSEX | -1.2% |
-2.6% |
-5.2% |
You may also like the below Video Courses